Sponsored Events

Contract-Biotechnology.com is routinely participating in international partnering and conferences. The following event are sponsored by Contract-Biotechnology.com




SMi’s 5th Pharmaceutical Microbiology West Coast Conference

Conference: June 20 – 21, 2022

Workshop: June, 22, 2022
San Diego, CA, USA


Sponsored by: Associates of Cape Cod, Bioscience International and Ecolab

Assuring end-patient safety through holistic contamination control

Conference Chairman: Don Singer, USP General Chapter Committee, Microbiology Chair, US Pharmacopeia and ECOLAB


Following on the success of the previous West Coast events, we are delighted to announce SMi’s 5th Annual Pharmaceutical Microbiology West Coast conference taking place in San Diego on June 20th and 21st,2022.   

Microbiology remains an essential tool for the detection of microorganisms to protect patients globally. The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revised industry regulation, enhanced knowledge of innovative therapies, and novel testing methods, this industry is ever expanding.

This conference will explore the most pressing topics in this thriving field, from the movement toward process automation and minimisation of operator intervention, to the latest technologies in rapid microbiological testing methods and data integrity

Join industry experts to discuss the latest topics and pressing challenges in this field. 

Network with professionals, discuss revisions in regulatory and guidance documents, explore data integrity considerations and approaches for conventional and rapid microbiology methods, discuss optimised environmental monitoring to best control contamination and gain insight into an industry perspective on alternative endotoxin testing methods and process automation, all contributing to better management of contamination in biopharmaceutical manufacturing.






Oligonucleotide Therapeutics and Delivery Conference 2022

Date: 21st – 22nd September 2022

Location: London, UK

Website: http://www.oligonucleotide.co.uk/ContractBiotechnology

Advancements in extra-hepatic delivery of oligonucleotides

The Oligonucleotide Therapeutics and Delivery conference reveals the latest in oligonucleotide discovery and delivery, with presentations on targeted delivery mechanisms, oligonucleotide chemistries and important clinical advances. Global experts from big pharma and leading biotechs will explore the emerging therapeutic applications of oligonucleotides with case studies surrounding the discovery and development of oligonucleotide therapeutics as well as CMC and regulatory standpoints. The two-day conference will bring you high-quality insights and industry connections on the latest clinical trial candidates and a platform for exchanging ideas for tackling the biggest challenge: DELIVERY.

Established on the success of our RNA Therapeutics series, we look forward to welcoming you at Oligonucleotide Therapeutics and Delivery to join the conversation around maximizing the potential of oligo-based treatments.


SAE Media Group’s 2nd Annual Biosensors for Medical Wearables

*In collaboration with Medical Design Briefs*

24th – 25th October 2022 | Boston, MA, USA

Sponsored by: Raumedic


Advances in development and therapeutic applications of on-body sensors

SAE Media Group is proud to present the Biosensors for Medical Wearables Conference, taking place on the 24th - 25th October 2022.

As part of SAE Media Group’s leading series of medical device conferences, this year’s event will be exploring the key drivers and innovations of the wearable medical biosensors landscape with insights into the latest technologies uncovering the therapeutic scope of medical biosensors and the potential of wearable sensors for decentralized diagnostic testing. With growing digital application, the 2022 agenda will also assess the potential of Artificial Intelligence coupled with sensors and understand how industry is managing digital outcomes.

Chairing the Conference this year will be industry giants James Mault, MD, Founder and CEO, BioIntelliSense, Inc and Andreas Caduff, Strategic Advisory Board, Digital Medicine Society (DiMe).